Figure 6 In vivo testing and analysis of lead compound to understand its efficiency and toxicity in a mouse model. The lead compound to be validated is injected into a mouse infected with COVID-19. This mouse is then observed for any changes in the disease condition. If the mouse shows an improvement in the disease outcome, then the drug injected is considered for further evaluation through human trials.